Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P F Schellhammer

Showing results (201-210 of 215) with videos related to

Pageof 22
Sort By:
Urology|April 1, 1996
A dose-response study of the effect of flutamide on benign prostatic hyperplasia: results of a multicenter studyP Narayan, J Trachtenberg, H Lepor, et al.
Urology|July 1, 1996
Bropirimine immunotherapy of upper urinary tract carcinoma in situM F Sarosdy, L L Pisters, P R Carroll, et al.
Urology|April 10, 1999
Does long-term finasteride therapy affect the histologic features of benign prostatic tissue and prostate cancer on needle biopsy? PLESS Study Group. Proscar Long-Term Efficacy and Safety StudyX J Yang, K Lecksell, K Short, et al.
The Journal of Urology|May 1, 1997
Prostate specific antigen decreases after withdrawal of antiandrogen therapy with bicalutamide or flutamide in patients receiving combined androgen blockadeP F Schellhammer, P Venner, G P Haas, et al.
The Prostate|July 27, 1999
Exploratory analysis on the effect of race on clinical outcome in patients with advanced prostate cancer receiving bicalutamide or flutamide, each in combination with LHRH analogues. The Casodex Combination Study GroupD G McLeod, P F Schellhammer, N J Vogelzang, et al.
Urology|July 22, 1998
Comparison of goserelin and leuprolide in combined androgen blockade therapyM F Sarosdy, P F Schellhammer, R Sharifi, et al.
Urologic Oncology|January 13, 2011
Randomized intergroup comparison of bacillus calmette-guerin immunotherapy and mitomycin C chemotherapy prophylaxis in superficial transitional cell carcinoma of the bladder a southwest oncology group studyD L Lamm, B A Blumenstein, E David Crawford, et al.
Urology|July 1, 1996
Oral bropirimine immunotherapy of carcinoma in situ of the bladder: results of a phase II trialM F Sarosdy, B A Lowe, P F Schellhammer, et al.
JAMA|August 28, 1996
Results of radical prostatectomy in men with clinically localized prostate cancerG S Gerber, R A Thisted, P T Scardino, et al.
Urologic Oncology|January 13, 2011
Prognostic significance of DNA ploidy in Ta/Tl bladder cancer: A southwest oncology group studyR W Devere White, A D Deitch, H Tesluk, et al.
Pageof 22

Showing results (201-210 of 215) with videos related to

Sort By:
Pageof 22
Urology|April 1, 1996
A dose-response study of the effect of flutamide on benign prostatic hyperplasia: results of a multicenter studyP Narayan, J Trachtenberg, H Lepor, et al.
Urology|July 1, 1996
Bropirimine immunotherapy of upper urinary tract carcinoma in situM F Sarosdy, L L Pisters, P R Carroll, et al.
Urology|April 10, 1999
Does long-term finasteride therapy affect the histologic features of benign prostatic tissue and prostate cancer on needle biopsy? PLESS Study Group. Proscar Long-Term Efficacy and Safety StudyX J Yang, K Lecksell, K Short, et al.
The Journal of Urology|May 1, 1997
Prostate specific antigen decreases after withdrawal of antiandrogen therapy with bicalutamide or flutamide in patients receiving combined androgen blockadeP F Schellhammer, P Venner, G P Haas, et al.
The Prostate|July 27, 1999
Exploratory analysis on the effect of race on clinical outcome in patients with advanced prostate cancer receiving bicalutamide or flutamide, each in combination with LHRH analogues. The Casodex Combination Study GroupD G McLeod, P F Schellhammer, N J Vogelzang, et al.
Urology|July 22, 1998
Comparison of goserelin and leuprolide in combined androgen blockade therapyM F Sarosdy, P F Schellhammer, R Sharifi, et al.
Urologic Oncology|January 13, 2011
Randomized intergroup comparison of bacillus calmette-guerin immunotherapy and mitomycin C chemotherapy prophylaxis in superficial transitional cell carcinoma of the bladder a southwest oncology group studyD L Lamm, B A Blumenstein, E David Crawford, et al.
Urology|July 1, 1996
Oral bropirimine immunotherapy of carcinoma in situ of the bladder: results of a phase II trialM F Sarosdy, B A Lowe, P F Schellhammer, et al.
JAMA|August 28, 1996
Results of radical prostatectomy in men with clinically localized prostate cancerG S Gerber, R A Thisted, P T Scardino, et al.
Urologic Oncology|January 13, 2011
Prognostic significance of DNA ploidy in Ta/Tl bladder cancer: A southwest oncology group studyR W Devere White, A D Deitch, H Tesluk, et al.
Pageof 22